Drugs

Taha Al-Juhaishi: Treatment of AML in the community setting

Photo from Taha Al-Juhaishi/X

Aug 23, 2024, 06:30

Taha Al-Juhaishi: Treatment of AML in the community setting

Taha Al-Juhaishi, Associate Director of Hematopoietic Stem Cell Transplantation and Cell Therapy at OU Health Cancer Center, shared on X:

“Hot off the press in The Oncologist Journal, our paper on treatment of AML in the community setting, I had the privilege of collaborating with outstanding group of oncologists and our colleagues at the FDA Oncology.”

Treatment of Acute Myeloid Leukemia in the Community Setting

Authors: Taha Al-Juhaishi, Servillano Dela Cruz, Rohan Gupta, Gina Keiffer, Vicki A Morrison, Iuliana Shapira, Ashley Woods, Kelly Norsworthy, Romeo Angelo de Claro, Marc R Theoret, Ravin Garg, Elizabeth Dianne Pulte

Treatment

Source: Taha Al-Juhaishi/X

Ashley Woods cancer Elizabeth Dianne Pulte FDA Oncology Gina Keiffer Iuliana Shapira Kelly Norsworthy Marc R. Theoret OncoDaily Oncology Ravin Garg Rohan Gupta Romeo Angelo de Claro Servillano Dela Cruz Taha Al-Juhaishi The Oncologist Journal Vicki A Morrison

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage